한국형 양극성 장애 약물치료 알고리듬 2026: 소아/청소년

Korean Medication Algorithm Project for Bipolar Disorder 2026: Children and Adolescents
  • 양찬모; 
  • 박원명; 
  • 우영섭; 
  • 정종현; 
  • 서정석; 
  • 외 12명

초록

Objectives The objective of this study was to revise the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) 2026 for children and adolescents. Methods A survey comprising 23 scenario-based questions on pediatric and adolescent bipolar disorder was administered to 60 experts in child and adolescent psychiatry, with 42 responding. Results For manic episodes in children, first-line pharmacotherapeutic strategies were a combination of mood stabilizer (MS) and atypical antipsychotics (AAP), MS monotherapy, and AAP monotherapy. Valproate was recommended as a first-line MS, while aripiprazole (treatment of choice [TOC]), risperidone, and quetiapine were selected as first-line AAPs. For depressive episodes in children, the first-line strategies were AAP monotherapy and a combination of MS and AAP. Lithium, aripiprazole (TOC), and lurasidone were recommended as first-line medications. For depressive episodes in children at high risk for bipolar disorder, AAP monotherapy was the firstline strategy. For manic and depressive episodes in adolescents, the first-line strategies were a combination of an MS and an AAP, MS monotherapy, and AAP monotherapy. Lithium, valproate, aripiprazole, quetiapine, risperidone, and olanzapine were selected as first-line medications for manic episodes. For depressive episodes in adolescents at high risk for bipolar disorder, the firstline strategies were AAP monotherapy and a combination of an MS and an AAP. Across adolescent and high-risk adolescent depressive episodes, lithium, valproate, lamotrigine, aripiprazole (TOC), lurasidone, quetiapine, and escitalopram were selected as first-line medications. Conclusion The KMAP-BP 2026 for children and adolescents is expected to provide clinical guidance to support clinicians in treating pediatric bipolar disorder.

키워드

Bipolar disorder; Children and adolescents; Pharmacotherapy; KMAP-BP 2026; 양극성 장애; 소아/청소년; 약물치료
제목
한국형 양극성 장애 약물치료 알고리듬 2026: 소아/청소년
제목 (타언어)
Korean Medication Algorithm Project for Bipolar Disorder 2026: Children and Adolescents
저자
양찬모; 박원명; 우영섭; 정종현; 서정석; 윤성훈; 전덕인; 박성용; 김원; 유빈; 김낙영; 최원석; 이문수; 양현주; 정영은; 김문두; 윤보현
DOI
10.4306/jknpa.2026.65.3.219
발행일
2026-08
유형
Y
저널명
Journal of Korean Neuropsychiatric Association
권
65
호
3
페이지
219 ~ 233